Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 187 pseudogene (RNU7-187P) is classified as a pseudogene in the human genome[7][11][5]. It shares sequence similarity with the functional U7 small nuclear RNA (snRNA) genes, which are components of the U7 small nuclear ribonucleoprotein (snRNP) complex involved in histone pre-mRNA 3′ end processing[2][3]. Pseudogenes like RNU7-187P are generally non-coding and do not produce functional snRNA or protein products; they are considered evolutionary remnants and are not believed to have direct biological or therapeutic roles[6][7]. RNU7-187P does not act as a therapeutic target, has no described molecular interactions or therapeutic ligands, and has no well-established roles as a biomarker or source of safety concern. It is distinct from functional U7 snRNA genes, which can be relevant in certain genetic and neurological disorders due to their role in histone mRNA maturation, but RNU7-187P itself is not implicated in such processes or diseases[7][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 187 pseudogene (RNU7-187P).